MYLAN MSA 375 MYLAN MSA 375 Pill - green capsule/oblong, 23mm
Pill with imprint MYLAN MSA 375 MYLAN MSA 375 is Green, Capsule/Oblong and has been identified as Mesalamine Extended-Release 375 mg (0.375 g). It is supplied by Mylan Pharmaceuticals Inc.
Mesalamine is used in the treatment of Ulcerative Colitis, Maintenance; Ulcerative Colitis, Active; Crohn's Disease, Maintenance; Inflammatory Bowel Disease; Ulcerative Colitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 375 mg (0.375 g) is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN MSA 375 MYLAN MSA 375

Mesalamine Extended-Release
- Imprint
- MYLAN MSA 375 MYLAN MSA 375
- Strength
- 375 mg (0.375 g)
- Color
- Green
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- 5-aminosalicylates
- Pregnancy Category
- B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1375
More about mesalamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (426)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5-aminosalicylates
- Breastfeeding
Patient resources
- Mesalamine drug information
- Mesalamine rectal
- Mesalamine (Oral) (Advanced Reading)
- Mesalamine (Rectal) (Advanced Reading)
- Mesalamine Rectal Enema
- Mesalamine Suppositories
Other brands
Lialda, Pentasa, Apriso, Asacol HD, ... +4 more
Professional resources
- Mesalamine monograph
- Mesalamine (FDA)
- Mesalamine Capsules (FDA)
- Mesalamine Controlled-Release Capsules (FDA)
- Mesalamine Delayed Release Tablets (FDA)
Other brands
Lialda, Pentasa, Apriso, Asacol, ... +5 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.